Cargando…

Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan

IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complem...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Toru, Aizawa, Kenichi, Shibuya, Kenji, Yamanaka, Shinya, Anzai, Yuichiro, Kurokawa, Kiyoshi, Nagai, Ryozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856923/
https://www.ncbi.nlm.nih.gov/pubmed/36574249
http://dx.doi.org/10.1001/jamanetworkopen.2022.47704
_version_ 1784873747769982976
author Suzuki, Toru
Aizawa, Kenichi
Shibuya, Kenji
Yamanaka, Shinya
Anzai, Yuichiro
Kurokawa, Kiyoshi
Nagai, Ryozo
author_facet Suzuki, Toru
Aizawa, Kenichi
Shibuya, Kenji
Yamanaka, Shinya
Anzai, Yuichiro
Kurokawa, Kiyoshi
Nagai, Ryozo
author_sort Suzuki, Toru
collection PubMed
description IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complementary analysis for symptomatic patients as reported by active epidemiologic surveillance used by the government. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of a sentinel screening program investigated approximately 1 million asymptomatic individuals with polymerase chain reaction (PCR) testing for SARS-CoV-2 infection between February 22 and December 8, 2021. Participants included children, students, employed adults, and older individuals, as well as volunteers to broadly reflect the general Japanese population in the 14 prefectures of Japan that declared a state of emergency. Saliva samples and a cycle threshold (Ct) value of approximately 40 as standard in Japan were used. Polymerase chain reaction testing for symptomatic patients was separately done by public health authorities, and the results were obtained from the Ministry of Health, Labour, and Welfare of Japan to complement data on asymptomatic infections from the present study. MAIN OUTCOMES AND MEASURES: Temporal trends in positivity and prevalence (including surges of different variants) and demographic associations (eg, age, geographic location, and vaccination status) were assessed. RESULTS: The positive rate of SARS-CoV-2 infection in 1 082 976 asymptomatic individuals (52.08% males; mean [SD] age 39.4 [15.7] years) was 0.03% (95% CI, 0.02%-0.05%) during periods without surges and a maximum of 0.33% (95% CI, 0.25%-0.43%) during peak surges at the Japanese standard Ct value of approximately 40; however, the positive rate would have been 10-fold less at a Ct value of 25 as used elsewhere in the world (eg, UK). There was an increase in patients with a positive PCR test result with a Ct value of 25 or 30 preceding surges in infection and hotspots of asymptomatic infections. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of asymptomatic SARS-CoV-2 infection in the general population of Japan in 2021, as investigated by sentinel surveillance, a low rate of infection was seen in the Japanese population compared with reported levels elsewhere in the world. This finding provides real-world data on the state of infection in Japan.
format Online
Article
Text
id pubmed-9856923
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-98569232023-02-03 Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan Suzuki, Toru Aizawa, Kenichi Shibuya, Kenji Yamanaka, Shinya Anzai, Yuichiro Kurokawa, Kiyoshi Nagai, Ryozo JAMA Netw Open Original Investigation IMPORTANCE: Real-world evidence of SARS-CoV-2 transmission is needed to understand the prevalence of infection in the Japanese population. OBJECTIVE: To conduct sentinel screening of the Japanese population to determine the prevalence of SARS-CoV-2 infection in asymptomatic individuals, with complementary analysis for symptomatic patients as reported by active epidemiologic surveillance used by the government. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of a sentinel screening program investigated approximately 1 million asymptomatic individuals with polymerase chain reaction (PCR) testing for SARS-CoV-2 infection between February 22 and December 8, 2021. Participants included children, students, employed adults, and older individuals, as well as volunteers to broadly reflect the general Japanese population in the 14 prefectures of Japan that declared a state of emergency. Saliva samples and a cycle threshold (Ct) value of approximately 40 as standard in Japan were used. Polymerase chain reaction testing for symptomatic patients was separately done by public health authorities, and the results were obtained from the Ministry of Health, Labour, and Welfare of Japan to complement data on asymptomatic infections from the present study. MAIN OUTCOMES AND MEASURES: Temporal trends in positivity and prevalence (including surges of different variants) and demographic associations (eg, age, geographic location, and vaccination status) were assessed. RESULTS: The positive rate of SARS-CoV-2 infection in 1 082 976 asymptomatic individuals (52.08% males; mean [SD] age 39.4 [15.7] years) was 0.03% (95% CI, 0.02%-0.05%) during periods without surges and a maximum of 0.33% (95% CI, 0.25%-0.43%) during peak surges at the Japanese standard Ct value of approximately 40; however, the positive rate would have been 10-fold less at a Ct value of 25 as used elsewhere in the world (eg, UK). There was an increase in patients with a positive PCR test result with a Ct value of 25 or 30 preceding surges in infection and hotspots of asymptomatic infections. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of asymptomatic SARS-CoV-2 infection in the general population of Japan in 2021, as investigated by sentinel surveillance, a low rate of infection was seen in the Japanese population compared with reported levels elsewhere in the world. This finding provides real-world data on the state of infection in Japan. American Medical Association 2022-12-27 /pmc/articles/PMC9856923/ /pubmed/36574249 http://dx.doi.org/10.1001/jamanetworkopen.2022.47704 Text en Copyright 2022 Suzuki T et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Suzuki, Toru
Aizawa, Kenichi
Shibuya, Kenji
Yamanaka, Shinya
Anzai, Yuichiro
Kurokawa, Kiyoshi
Nagai, Ryozo
Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title_full Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title_fullStr Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title_full_unstemmed Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title_short Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
title_sort prevalence of asymptomatic sars-cov-2 infection in japan
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856923/
https://www.ncbi.nlm.nih.gov/pubmed/36574249
http://dx.doi.org/10.1001/jamanetworkopen.2022.47704
work_keys_str_mv AT suzukitoru prevalenceofasymptomaticsarscov2infectioninjapan
AT aizawakenichi prevalenceofasymptomaticsarscov2infectioninjapan
AT shibuyakenji prevalenceofasymptomaticsarscov2infectioninjapan
AT yamanakashinya prevalenceofasymptomaticsarscov2infectioninjapan
AT anzaiyuichiro prevalenceofasymptomaticsarscov2infectioninjapan
AT kurokawakiyoshi prevalenceofasymptomaticsarscov2infectioninjapan
AT nagairyozo prevalenceofasymptomaticsarscov2infectioninjapan